Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan
Oncology · 2025
DOI: 10.1159/000548812 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Oncology, 2025. Verfasst von Yasutaka Ihara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Promotion Unit, Clinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Protein Kinase Inhibitors, Lung Neoplasms, Drug Monitoring. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
The prognosis of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer has improved with the introduction of oral EGFR-tyrosine kinase inhibitor (TKI). Lower adherence to oral anticancer medications is reportedly associated with a poor prognosis. It is important to understand the causes of lower adherence to oral anticancer medications. We aimed to assess the potential risk factors associated with low adherence to EGFR-TKIs in a real-world clinical setting using administrative claims data in Japan.
Methods
We identified 10,809 outpatients routinely prescribed EGFR-TKIs between December 2015 and January 2023. Adherence to EGFR-TKIs was assessed based on the medication possession ratio (MPR) during the 12-month follow-up period from the date of first outpatient EGFR-TKI prescription. Multivariable linear regression analysis was performed to identify the potential risk factors associated with lower adherence.
Results
The mean (standard deviation) MPR was 94.1% (14.0). Lower adherence was associated with increasing age (per 10-year increase), female sex, dysphagia, and a higher number of concomitant oral medications (per doubling of the count).
Conclusion
Adherence to EGFR-TKIs was generally high, but the findings support tailored adherence strategies, especially for older patients and for those with a higher number of concomitant oral medications, including medication review to reduce pill burden and proactive support for swallowing difficulties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Promotion Unit, Clinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
- Center for Data Science, Ehime University, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
- Integrated Medical and Agricultural School of Public Health, Ehime University, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
- Department of Cardiology, Pulmonology, Hypertension and Nephrology, Graduate School of Medicine, Ehime University, Ehime, Japan.
- Department of Clinical Oncology, Ehime University Graduate School of Medicine, Ehime University, Ehime, Japan.
- Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Zitieren
APA
Ihara, Y., Yamamoto, S., Mizutani, M., Akiyama, S., Okada, N., & Shimomura, Y. (2025). Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Oncology. https://doi.org/10.1159/000548812
Vancouver
Ihara Y, Yamamoto S, Mizutani M, Akiyama S, Okada N, Shimomura Y. Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Oncology. 2025. doi:10.1159/000548812
BibTeX
@article{Ihara2025,
author = {Ihara, Yasutaka and Yamamoto, Shoichiro and Mizutani, Megumi and Akiyama, Shinji and Okada, Naoto and Shimomura, Yuki},
title = {Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan},
journal = {Oncology},
year = {2025},
doi = {10.1159/000548812}
}
EUVIMED